1921
Volume 83, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Our objective was to characterize both epidemiologically and clinically manifestations after severe scorpion envenomation and to define simple factors indicative of poor prognosis in children. We performed a retrospective study over 13 years (1990–2002) in the medical intensive care unit (ICU) of a university hospital (Sfax-Tunisia). The diagnosis of scorpion envenomation was based on a history of scorpion sting. The medical records of 685 children aged less than 16 years who were admitted for a scorpion sting were analyzed. There were 558 patients (81.5%) in the grade III group (with cardiogenic shock and/or pulmonary edema or severe neurological manifestation [coma and/or convulsion]) and 127 patients (18.5%) in the grade II group (with systemic manifestations). In this study, 434 patients (63.4%) had a pulmonary edema, and 80 patients had a cardiogenic shock; neurological manifestations were observed in 580 patients (84.7%), 555 patients (81%) developed systemic inflammatory response syndrome (SIRS), and 552 patients (80.6%) developed multi-organ failure. By the end of the stay in the ICU, evolution was marked by the death in 61 patients (8.9%). A multivariate analysis found the following factors to be correlated with a poor outcome: coma with Glasgow coma score ≤ 8/15 (odds ratio [OR] = 1.3), pulmonary edema (OR = 2.3), and cardiogenic shock (OR = 1.7). In addition, a significant association was found between the development of SIRS and heart failure. Moreover, a temperature > 39°C was associated with the presence of pulmonary edema, with a sensitivity at 20.6%, a specificity at 94.4%, and a positive predictive value at 91.7%. Finally, blood sugar levels above 15 mmol/L were significantly associated with a heart failure. In children admitted for severe scorpion envenomation, coma with Glasgow coma score ≤ 8/15, pulmonary edema, and cardiogenic shock were associated with a poor outcome. The presence of SIRS, a temperature > 39°C, and blood sugar levels above 15 mmol/L were associated with heart failure.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2010.10-0036
2010-11-05
2017-09-22
Loading full text...

Full text loading...

/deliver/fulltext/14761645/83/5/1084.html?itemId=/content/journals/10.4269/ajtmh.2010.10-0036&mimeType=html&fmt=ahah

References

  1. Chippaux J-P, Goyffon M, , 2008. Epidemiology of scorpionism: a global appraisal. Acta Trop 107: 7179.[Crossref]
  2. Mansour N, , 2001. Délai et caractéristiques de la prise en charge des piqués par scorpion dans la région de Sidi-Bouzid. Arch Inst Pasteur Tunis 78: 2531.
  3. Njah A, Abdelaziz B, Abdouli M, Zaher M, Garaoui A, , 2001. Programmes de santé et recours aux agents de santé communautaire: l'exemple de l'envenimation scorpionique en Tunisie. Cahiers d'Etudes et de Recherches Francophones/Santé 11: 5762.
  4. Goyffon M, Vachon N, Broglio N, , 1982. Epidemiological and clinical characteristics of the scorpion envenomation in Tunisia. Toxicon 20: 337344.[Crossref]
  5. Bouaziz M, Bahloul M, Kallel H, Samet M, Ksibi H, Dammak H, Ahmed MN, Chtara K, Chelly H, Hamida CB, Rekik N, , 2008. Epidemiological, clinical characteristics and outcome of severe scorpion envenomation in south Tunisia: multivariate analysis of 951 cases. Toxicon 52: 918926.[Crossref]
  6. Santhanakrishnan BR, Gajalakshmi BS, , 1986. Pathogenesis of cardiovascular complications in children following scorpion envenoming. Ann Trop Paediatr 6: 117121.[Crossref]
  7. Sofer S, Gueron M, White RM, Lifshitz M, Apte RN, , 1996. Interleukin-6 release following scorpion sting in children. Toxicon 34: 389392.[Crossref]
  8. Krifi MN, Kharrat H, Zghal K, Abdouli M, Abroug F, Bouchoucha S, Dellagi K, El Ayeb M, , 1998. Development of an ELISA for the detection of scorpion venoms in sera of humans envenomed by AAG and BOT: correlation with clinical severity of envenoming in Tunisia. Toxicon 36: 887900.[Crossref]
  9. Pollack MM, Patel KM, Ruttimann UE, , 1996. PRISM III: an updated Pediatric Risk of Mortality score. Crit Care Med 24: 743752.[Crossref]
  10. Simpson D, Reilly P, , 1982. Pediatric coma scale. Lancet 2: 450.[Crossref]
  11. Bahloul M, Ben Hamida C, Chtourou K, Ksibi H, Dammak H, Kallel H, Chaari A, Chelly H, Guermazi F, Rekik N, Bouaziz M, , 2004. Evidence of myocardial ischemia in severe scorpion envenomation: “myocardial perfusion scintigraphy study. Intensive Care Med 30: 461467.[Crossref]
  12. Elatrous S, Nouira S, Besbes-Ouanes L, Boussarsar M, Boukef R, Marghli S, Abroug F, , 1999. Dobutamine in severe scorpion envenomation: effects on standard hemodynamics, right ventricular performance, and tissue oxygenation. Chest 116: 748755.[Crossref]
  13. Tran DD, Groeneveld AB, van der Meulen J, Nauta JJ, Strack van Schijndel RJ, Thijs LG, , 1990. Age, chronic disease, sepsis, organ system failure, and mortality in a medical intensive care unit. Crit Care Med 18: 474479.[Crossref]
  14. Qureshi SS, Qureshi SS, Lewis SM, Gant VA, Treacher D, Davis BH, Brown KA, 2001. Increased distribution and expression of CD64 on blood polymorphonuclear cells from patients with the systemic inflammatory response syndrome (SIRS). Clin Exp Immunol 125: 258265.[Crossref]
  15. Hanley JA, McNeill BJ, , 1982. The meaning and use of the area under a receiver operator-characteristic (ROC) curve. Radiology 143: 2936.[Crossref]
  16. Nouira S, Boukef R, Nciri N, Haguiga H, Elatrous S, Besbes L, Letaief M, Abroug F, , 2007. A clinical score predicting the need for hospitalization in scorpion envenomation. Am J Emerg Med 25: 414419.[Crossref]
  17. Sofer S, Gueron M, , 1988. Respiratory failure in children following envenomation by the scorpion Leiurus quinquestriatus: hemodynamic and neurological aspects. Toxicon 26: 931939.[Crossref]
  18. Bouaziz M, Bahloul M, Hergafi L, Kallel H, Chaari L, Hamida CB, Chaari A, Chelly H, Rekik N, , 2006. Factors associated with pulmonary edema in severe scorpion sting patients—a multivariate analysis of 428 cases. Clin Toxicol (Phila) 44: 293300.[Crossref]
  19. Nunan EA, Moraes MFD, Cardoso VN, Moraes-Santos T, , 2003. Effet de l'age sur la distribution de la toxine du venin du Tityus serrulatus dans le corps chez les rats. Life Sci 73: 319325.[Crossref]
  20. Krishna-Murthy, 2000. The scorpion envenoming syndrome: a different perspective. The physiological basis of the role of insulin in scorpion envenoming. J Venom Anim Toxins 61: 451.
  21. Yarom R, Braun K, , 1971. Electron microscopic studies of the myocardial changes produced by scorpion venom. Lab Invest 24: 2130.
  22. Wang R, Moreau P, Deschamps A, de Champlain J, Sauve R, Foucart S, Bai L, Lu XR, , 1994. Cardiovascular effects of Buthus martensii (Karsch) scorpion venom. Toxicon 32: 191200.[Crossref]
  23. Meki AR, Mohey El-Dean ZM, , 1998. Serum interleukin-1beta, interleukin-6, nitric oxide and alpha1-antitrypsin in scorpion envenomed children. Toxicon 36: 18511859.[Crossref]
  24. Meki Abdel-Raheem AM, Mohamed Zeinab MM, Hasan M, Mohey E, , 2003. Significance of assessment of serum cardiac troponin I and interleukin-8 in scorpion envenomed children. Toxicon 41: 129137.[Crossref]
  25. Meki AR, Hasan HA, El-Deen ZM, Bakkar S, , 2003. Dysregulation of apoptosis in scorpion envenomed children: its reflection on their outcome. Toxicon 42: 229237.[Crossref]
  26. Pessini AC, Kanashiro A, Malvar Ddo C, Machado RR, Soares DM, Figueiredo MJ, Kalapothakis E, Souza GE, , 2008. Inflammatory mediators involved in the nociceptive and oedematogenic responses induced by Tityus serrulatus scorpion venom injected into rat paws. Toxicon 52: 729736.[Crossref]
  27. Fukuhara YDM, Reis ML, Dellalibera-Joviliano R, Cunha FQC, Donadi EA, , 2003. Increased plasma levels of IL- 1β, IL-6, IL-8, IL-10 and TNF-α in patients moderately or severely envenomed by Tityus serrulatus scorpion sting. Toxicon 41: 4955.[Crossref]
  28. D'Suze G, Moncada S, Gonzalez C, Sevcik C, Aguilar V, Alagón A, , 2003. Relationship between plasmatic levels of various cytokines, tumor necrosis factor, enzymes, glucose and venom concentration following Tityus scorpion sting. Toxicon 41: 367375.[Crossref]
  29. Abdel-Haleem AH, Meki AR, Noaman HA, Mohamed ZT, , 2006. Serum levels of IL-6 and its soluble receptor, TNF-α and chemokine RANTES in scorpion envenomed children: their relation to scorpion envenomation outcome. Toxicon 47: 437444.[Crossref]
  30. de Roodt AR, García SI, Salomón OD, Segre L, Dolab JA, Funes RF, de Titto EH, , 2003. Epidemiological and clinical aspects of scorpionism by Tityus trivittatus in Argentina. Toxicon 41: 971977.[Crossref]
  31. El amine EO., 1992. Issues in management of scorpion sting in children. Toxicon 30: 111115.[Crossref]
  32. Osnaya-Romero N, de Jesus Medina-Hernández T, Flores-Hernández SS, León-Rojas G, , 2001. Clinical symptoms observed in children envenomed by scorpion stings, at the children's hospital from the State of Morelos, Mexico. Toxicon 39: 781785.[Crossref]
  33. Carvalho FF, Nencioni ALA, Lebrun I, Dorce VAC, Sandoval MRL, , 2003. Convulsive effects of some isolated venom fractions of the Tityus serrulatus scorpion: behavioral, electroencephalographic, and neuropathological aspects J Venom Anim Toxins 6: 238260.
  34. Magalhães MM, Pereira ME, Amaral CF, Rezende NA, Campolina D, Bucaretchi F, Gazzinelli RT, Cunha-Melo JR, , 1999. Serum levels of cytokines in patients envenomed by Tityus serrulatus scorpion sting. Toxicon 37: 11551164.[Crossref]
  35. Farghly WM, Ali FA, , 1999. A clinical and neurophysiological study of scorpion envenomation in Assiut, Upper Egypt. Acta Paediatr 88: 290294.[Crossref]
  36. Bahloul M, Chaari A, Khlaf-Bouaziz N, Hergafi L, Ksibi H, Kallel H, Chaari A, Chelly H, Ben Hamida C, Rekik N, Bouaziz M, , 2005. Gastrointestinal manifestations in severe scorpion envenomation. Gastroenterol Clin Biol 29: 10011005.[Crossref]
  37. Bahloul M, Rekik N, Chabchoub I, Chaari A, Ksibi H, Kallel H, Damak H, Chaari A, Ben Hamida C, Chelly H, Bouaziz M, , 2005. Neurological complications secondary to severe scorpion envenomation. Med Sci Monit 11: CR196CR202.
  38. Abrough F, Nouira S, Boujdaria R, , 1992. Cardiac dysfunction and pulmonary edema following scorpion envenomation. Chest 102: 13081309.[Crossref]
  39. Gueron M, Adoleph R, Grup TL, , 1980. Hemodynamic and myocardial consequences of scorpion venom. Am J Cardiol 45: 979986.[Crossref]
  40. Gueron M, Illia R, Sofer S, , 1992. The cardiovascular system after scorpion envenomation: a review. J Toxicol Clin Toxicol 30: 245258.[Crossref]
  41. Teixeira AL, Fontoura BF, Freire-Maia L, Machado CR, Camargos ER, Teixeira MM, , 2001. Evidence for a direct action of Tityus serrulatus scorpion venom on the cardiac muscle. Toxicon 39: 703709.[Crossref]
  42. Nouira S, Abroug F, Haguiga H, , 1995. Right ventricular dysfunction following severe scorpion envenomation. Chest 108: 682687.[Crossref]
  43. Clarke RSJ, Johnston H, Sheridan B, , 1970. The influence of anaesthesis and surgery on plasma cortisol, insulin and free fatty acids. Br J Anaesth 42: 295299.[Crossref]
  44. Bahloul M, Kallel H, Rekik N, Ben Hamida C, Chelly H, Bouaziz M, , 2005. Cardiovascular dysfunction following severe scorpion envenomation. Mechanisms and physiopathology. Presse Med 34: 115120.[Crossref]
  45. Oswald GA, Smith CC, Delamothe AP, Betteridge DJ, Yudkin JS, , 1988. Raised concentrations of glucose and adrenaline and increased in vivo platelet activation after myocardial infarction. Br Heart J 59: 663671.[Crossref]
  46. Verma S, Maitland A, Weisel RD, Li SH, Fedak PW, Pomroy NC, Mickle DA, Li RK, Ko L, Rao V, , 2002. Hyperglycemia exaggerates ischemia-reperfusion-induced cardiomyocyte injury: reversal with endothelin antagonism. J Thorac Cardiovasc Surg 123: 11201124.[Crossref]
  47. Krifi MN, Amri F, Kharrat H, El Ayeb M, , 1999. Evaluation of antivenom therapy in children severely envenomed by Androctonus australis garzonii (Aag) and Buthus occitanus tunetanus (Bot) scorpions. Toxicon 11: 16271634.[Crossref]
  48. Dehesa-Dávila M, Possani LD, , 1994. Scorpionism and serotherapy in Mexico. Toxicon 32: 10151018.[Crossref]
  49. Rezende NA, Amaral CF, Freire-Maia L, , 1998. Immunotherapy for scorpion envenoming in Brazil. Toxicon 36: 15071513.[Crossref]
  50. Sofer S, Shahak E, Gueron M, , 1994. Scorpion envenomation and antivenom therapy. J Pediatr 124: 973978.[Crossref]
  51. Bawaskar HS, Bawaskar PH, , 2007. Utility of scorpion antivenin vs prazosin in the management of severe Mesobuthus tamulus (Indian red scorpion) envenoming at rural setting. J Assoc Physicians India 55: 1421.
  52. Boyer LV, Theodorou AA, Berg RA, Mallie J, Arizona Envenomation Investigators Chávez-Méndez A, García-Ubbelohde W, Hardiman S, Alagón A, , 2009. Antivenom for critically ill children with neurotoxicity from scorpion stings. N Engl J Med 360: 20902098.[Crossref]
  53. Abroug F, ElAtrous S, Nouira S, Haguiga H, Touzi N, Bouchoucha S, , 1999. Serotherapy in scorpion envenomation: a randomised controlled trial. Lancet 354: 906909.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2010.10-0036
Loading
/content/journals/10.4269/ajtmh.2010.10-0036
Loading

Data & Media loading...

  • Received : 18 Dec 2010
  • Accepted : 19 Apr 2010

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error